0001413329false00014133292024-03-072024-03-070001413329us-gaap:CommonStockMember2024-03-072024-03-070001413329pm:A2.875Notesdue20241Member2024-03-072024-03-070001413329pm:A2.875Notesdue20242Member2024-03-072024-03-070001413329pm:A0.625Notesdue2024Member2024-03-072024-03-070001413329pm:A3.250Notesdue2024Member2024-03-072024-03-070001413329pm:A2.750Notesdue2025Member2024-03-072024-03-070001413329pm:A3.375Notesdue2025Member2024-03-072024-03-070001413329pm:A2.750Notesdue2026Member2024-03-072024-03-070001413329pm:A2.875Notesdue2026Member2024-03-072024-03-070001413329pm:A0.125Notesdue2026Member2024-03-072024-03-070001413329pm:A3.125Notesdue2027Member2024-03-072024-03-070001413329pm:A3.125Notesdue2028Member2024-03-072024-03-070001413329pm:A2.875Notesdue2029Member2024-03-072024-03-070001413329pm:A3.375Notesdue2029Member2024-03-072024-03-070001413329pm:A0.800Notesdue2031Member2024-03-072024-03-070001413329pm:A3.125Notesdue2033Member2024-03-072024-03-070001413329pm:A2.000Notesdue2036Member2024-03-072024-03-070001413329pm:A1.875Notesdue2037Member2024-03-072024-03-070001413329pm:A6.375Notesdue2038Member2024-03-072024-03-070001413329pm:A1.450Notesdue2039Member2024-03-072024-03-070001413329pm:A4.375Notesdue2041Member2024-03-072024-03-070001413329pm:A4.500Notesdue2042Member2024-03-072024-03-070001413329pm:A3.875Notesdue2042Member2024-03-072024-03-070001413329pm:A4.125Notesdue2043Member2024-03-072024-03-070001413329pm:A4.875Notesdue2043Member2024-03-072024-03-070001413329pm:A4.250Notesdue2044Member2024-03-072024-03-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 7, 2024
Philip Morris International Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Virginia |
|
1-33708 |
|
13-3435103 |
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 677 Washington Blvd, Ste. 1100 |
Stamford |
Connecticut |
|
|
06901 |
| (Address of principal executive offices) |
|
|
(Zip Code) |
Registrant's telephone number, including area code: (203) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
|
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
|
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
|
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
|
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, no par value |
|
PM |
|
New York Stock Exchange |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.875% Notes due 2024 |
|
PM24 |
|
New York Stock Exchange |
| 2.875% Notes due 2024 |
|
PM24C |
|
New York Stock Exchange |
| 0.625% Notes due 2024 |
|
PM24B |
|
New York Stock Exchange |
| 3.250% Notes due 2024 |
|
PM24A |
|
New York Stock Exchange |
| 2.750% Notes due 2025 |
|
PM25 |
|
New York Stock Exchange |
| 3.375% Notes due 2025 |
|
PM25A |
|
New York Stock Exchange |
| 2.750% Notes due 2026 |
|
PM26A |
|
New York Stock Exchange |
| 2.875% Notes due 2026 |
|
PM26 |
|
New York Stock Exchange |
| 0.125% Notes due 2026 |
|
PM26B |
|
New York Stock Exchange |
| 3.125% Notes due 2027 |
|
PM27 |
|
New York Stock Exchange |
| 3.125% Notes due 2028 |
|
PM28 |
|
New York Stock Exchange |
| 2.875% Notes due 2029 |
|
PM29 |
|
New York Stock Exchange |
| 3.375% Notes due 2029 |
|
PM29A |
|
New York Stock Exchange |
| 0.800% Notes due 2031 |
|
PM31 |
|
New York Stock Exchange |
| 3.125% Notes due 2033 |
|
PM33 |
|
New York Stock Exchange |
| 2.000% Notes due 2036 |
|
PM36 |
|
New York Stock Exchange |
| 1.875% Notes due 2037 |
|
PM37A |
|
New York Stock Exchange |
| 6.375% Notes due 2038 |
|
PM38 |
|
New York Stock Exchange |
| 1.450% Notes due 2039 |
|
PM39 |
|
New York Stock Exchange |
| 4.375% Notes due 2041 |
|
PM41 |
|
New York Stock Exchange |
| 4.500% Notes due 2042 |
|
PM42 |
|
New York Stock Exchange |
| 3.875% Notes due 2042 |
|
PM42A |
|
New York Stock Exchange |
| 4.125% Notes due 2043 |
|
PM43 |
|
New York Stock Exchange |
| 4.875% Notes due 2043 |
|
PM43A |
|
New York Stock Exchange |
| 4.250% Notes due 2044 |
|
PM44 |
|
New York Stock Exchange |
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
|
|
|
|
|
|
|
Emerging growth company |
☐ |
|
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
☐ |
|
|
|
|
|
|
Item 7.01. |
Regulation FD Disclosure. |
On March 7, 2024, Philip Morris International Inc. issued a press release announcing that its Board of Directors declared a regular quarterly dividend of $1.30 per common share, which press release is attached as Exhibit 99.1 to this Item 7.01 of this Current Report on Form 8-K and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such filing or document.
|
|
|
|
|
|
Item 9.01. |
Financial Statements and Exhibits. |
|
|
|
|
|
|
| 104 |
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
| PHILIP MORRIS INTERNATIONAL INC. |
|
|
| By: |
|
/s/ DARLENE QUASHIE HENRY |
| Name: |
|
Darlene Quashie Henry |
| Title: |
|
Vice President, Associate General Counsel & Corporate Secretary |
Date: March 7, 2024
EX-99.1
2
april2024dividend.htm
EX-99.1
Document
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PRESS RELEASE |
|
|
|
|
|
|
|
| Investor Relations: |
|
Media: David Fraser |
|
|
| New York: +1 (917) 663 2233 |
|
Lausanne: +41 (0)58 242 4500 |
|
|
| Lausanne: +41 (0)58 242 4666 |
|
Email: David.Fraser@pmi.com |
|
|
| Email: InvestorRelations@pmi.com |
|
|
|
|
PHILIP MORRIS INTERNATIONAL INC.
DECLARES REGULAR QUARTERLY DIVIDEND OF $1.30 PER SHARE
STAMFORD, CT, March 7, 2024 – The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.30 per common share, payable on April 9, 2024, to shareholders of record as of March 21, 2024. The ex-dividend date is March 20, 2024. For more details on stock, dividends and other information, see www.pmi.com/dividend.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. As of December 31, 2023, PMI's smoke-free products were available for sale in 84 markets, and PMI estimates that approximately 20.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 37% of PMI’s total full-year 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.
エドガーで原本を確認する
